LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
MCF7	CP466722	0.04	uM	LJP5	2	I12	72	hr	1209	4593	4252	1.0800	1.0867
MCF7	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1209	638	4093	0.1558	-0.3049
MCF7	Sorafenib	0.04	uM	LJP6	1	B12	72	hr	1209	3591	3823	0.9393	0.9260
MCF7	CP466722	0.04	uM	LJP5	1	I12	72	hr	1209	4454	3980	1.1191	1.1353
MCF7	CP724714	0.04	uM	LJP5	2	A12	72	hr	1209	3767	4252	0.8858	0.8706
MCF7	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1209	702	3823	0.1836	-0.2794
MCF7	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1209	1977	4121	0.4797	0.3202
MCF7	AZD8055	0.04	uM	LJP6	2	A12	72	hr	1209	1244	4093	0.3039	0.0161
MCF7	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1209	4217	3980	1.0595	1.0684
MCF7	Sorafenib	0.04	uM	LJP6	3	B12	72	hr	1209	3898	4121	0.9458	0.9380
MCF7	CP466722	0.04	uM	LJP5	3	I12	72	hr	1209	4190	4376	0.9575	0.9537
MCF7	CP724714	0.04	uM	LJP5	1	A12	72	hr	1209	3849	3980	0.9671	0.9614
MCF7	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1209	1254	4121	0.3043	0.0206
MCF7	CP724714	0.04	uM	LJP5	3	A12	72	hr	1209	3823	4376	0.8736	0.8595
MCF7	Seliciclib	0.04	uM	LJP5	2	J06	72	hr	1209	4768	4252	1.1211	1.1301
MCF7	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1209	2009	4093	0.4907	0.3344
MCF7	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1209	1898	3823	0.4965	0.3118
MCF7	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1209	1413	3823	0.3696	0.0982
MCF7	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1209	1892	4093	0.4622	0.2896
MCF7	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1209	1843	4121	0.4472	0.2689
MCF7	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1209	1100	3823	0.2877	-0.0556
MCF7	Sorafenib	0.04	uM	LJP6	2	B12	72	hr	1209	3746	4093	0.9150	0.9015
MCF7	Seliciclib	0.04	uM	LJP5	3	J06	72	hr	1209	4350	4376	0.9940	0.9936
MCF7	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1209	2511	3823	0.6568	0.5526
MCF7	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1209	681	4121	0.1652	-0.2773

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)